We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
H.C. Wainwright analyst Robert Burns raised the firm’s price target on Nurix Therapeutics (NRIX) to $35 from $30 and keeps a Buy rating on the ...
During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced that it has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc. to advance a new ...
Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...